eye treatment biosimilar

Hanwha Solutions Corp., the chemical and renewable energy unit of South Korea’s No. 7 conglomerate Hanwha Group, and Taihan Cable & Soluti...

LG Energy Solution Ltd., the world’s third-largest electric vehicle battery maker, is poised to raise $2 billion in global bonds by the end of...

South Korea’s largest shipbuilder, HD Korea Shipbuilding & Offshore Engineering Co. (HD KSOE), is eyeing around $3.4 billion worth of orde...

LG Innotek Co., South Korea’s leading mobile camera module maker, is upping the ante to lead the automotive sensing market with high-performan...

Macquarie Group’s South Korean infrastructure investment arm is set to buy its first domestic data center, valued at up to 1 trillion won ($72...

Hyundai Motor Group will expand its cooperation with global companies to boost its presence in the hydrogen value chain from production to distribut...

South Korean spaceflight startup Innospace, which fired the country’s first private launch vehicle last year, aims to list on the Kosdaq in Ju...

SAN DIEGO – Samsung Biologics Co. is enjoying a stream of contract development and manufacturing order inquiries from big pharmaceutical compa...

Hong Kong-based Affinity Equity Partners is planning for an equity swap between its new entity and South Korean food container maker Lock&Lock...

SK Gas Ltd., South Korea’s leading liquefied petroleum gas (LPG) supplier seeking to transform into a clean energy company, has moved a step c...

South Korea’s online portal giant Naver Corp. is planning to list its Los Angeles-based affiliate Webtoon Entertainment Inc. on the Nasdaq thi...

STOCKHOLM – Samsung Bioepis Co.'s biosimilar to Soliris for the treatment of patients with rare, life-threatening disease paroxysmal nocturnal...

Hanwha Q Cells Co., a solar power unit of South Korean chemicals-to-defense conglomerate Hanwha Group, is striving for revenue stream diversificatio...

South Korean brokerage firms are scurrying to raise more than 1.7 trillion won ($1.24 billion) in private equity funds to bet on soured property loa...

South Korean pharmaceutical company Handok Inc. announced on Friday that it signed an exclusive domestic sales and distribution agreement with India...

WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...

Sovereign wealth fund Korea Investment Corporation (KIC) seeks opportunities in direct lending for companies that are not cyclically sensitive and g...

HLB Co. and its affiliate stocks tumbled on Friday on news that the South Korean biotech group’s highly anticipated new cancer treatment Rivoc...

South Korean biotech Xcell Therapeutics Inc., a developer of chemically defined media for in vitro cell culture, is aiming for a junior bourse Kosda...

OCI Holdings Co., South Korea’s largest polysilicon maker, is looking abroad to acquire a biopharmaceutical company in the US in a consortium,...

SKC Ltd., a chemicals arm of South Korea’s second-largest conglomerate SK Group, said on Sunday its biodegradable material unit has broken g...

South Korea’s No. 1 mobile carrier SK Telecom Co. is set to accelerate investments in artificial intelligence to bring more tangible outcomes ...

The global weight management market has entered a new chapter following the arrival of blockbuster weight-loss medication Wegovy, and South Korean l...

South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and antican...

HMM Co., South Korea’s leading sea carrier, announced on Friday its adoption of an advanced AI image analysis solution 'Deep Eyes', aimed at b...

NEW YORK – South Korea’s largest asset manager Samsung Asset Management Co. is leveraging its strategic partnership with a US investment...

South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara.&n...

China's Alibaba Group Holding Ltd. is likely to make its first investment in a South Korean online shopping platform as it aims to gain a competitiv...

South Korea's Celltrion Inc. announced on Thursday that it released its autoimmune disease treatment Remsima SC (infliximab) in Denmark. Remsima SC ...

North Asia-focused private equity firm MBK Partners is eyeing shares of South Korean enterprise software developer Tmaxsoft Co. around two years aft...